Type of hospitalisations and in-hospital outcomes in the Italian coronary care unit network at the time of COVID-19 pandemic: the BLITZ-COVID19 Registry. Issue 11 (29th November 2022)

• Record Type: Journal Article
• Authors: Gulizia, Michele Massimo; Fabbri, Gianna; Lucci, Donata; Di Pasquale, Giuseppe; Gabrielli, Domenico; Campodonico, Jeness; Mauro, Andrea; Inciardi, Riccardo; Di Lorenzo, Emilio; Oliva, Fabrizio; Nardi, Federico; Colivicchi, Furio; De Luca, Leonardo
• Is Part Of: BMJ open. Volume 12:Issue 11(2022)
• Publication Date: 2022-11-29
• Subjects: COVID-19 -- Coronary heart disease -- Cardiac Epidemiology -- Adult intensive & critical care; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2022-062382
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objective: The aim of the study was to describe the epidemiology and outcome of patients hospitalised during the COVID-19 pandemic in intensive cardiac care units (ICCs). Design: Non-interventional, retrospective and prospective, nationwide study. Setting: 109 private or public ICCs in Italy. Participants: 6054 consecutive patients admitted to Italian ICCs during COVID-19 pandemic. Primary and secondary outcome measures: To obtain accurate and up-to-date information on epidemiology and outcome of patients admitted to ICCs during the COVID-19 pandemic, the impact that the COVID-19 infection may have determined on the organisational pathways and in-hospital management of the various clinical conditions being admitted to ICCs. Results: Acute coronary syndromes were the most frequent ICC discharge diagnoses followed by heart failure and hypokinetic arrhythmias. The prevalence of COVID-19 positivity was approximately 3%. Most patients with a COVID-19 diagnosis at discharge (52%) arrived to ICC from other wards, in particular 22% from non-cardiology ICCs. The overall mortality was 4.2% during ICC and 5.8% during hospital stay. The cause of in-hospital death was cardiac in 74.4% of the cases, non-cardiovascular in 13.5%, vascular in 5.8% and related to COVID-19 in 6.3% of the patients. Conclusions: This study provides a unique nationwide picture of current ICC care during COVID-19 pandemic. Trial registration number: NCT04744415 .